glp-1 drugs and alzheimer's improves the neuronal supportive ability of astrocytes in disease by regulating mitochondrial dysfunction via the cAMP/PKA pathway How GLP-1s Could Transform Alzheimer's

Among RCTs, increased ketotic hyperglycemia events were reported in the ADJUNCT trials in a dose-related manner (48, 49)

Accelerated demand after Mounjaros launch Even before Mounjaros momentous debut, Ozempic demonstrated notable HbA1c reductions and weight loss results, and demand for GLP-1s grew at a steady rate (compound monthly growth of 2% from January 2020 to May 2021)

A study in female patients with obesity who were prescribed a 925 kcal diet for 16 weeks followed by a 12001500 kcal diet for 32 weeks showed 11% weight loss in the first 2 months with reductions in triglycerides and total cholesterol by 22.7% and 15.7% respectively [29]

Ruiz-Ojeda, F

[DOI] [PubMed] [Google Scholar] [158].Fineman MS, Mace KF, Diamant M, Darsow T, Cirincione BB, Booker Porter TK, Kinninger LA, Trautmann ME, Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment, Diabetes, obesity & metabolism, 14 (2012) 546554

Weight loss medications are not part of the standard program